Enbrel reimbursable for ankylosing spondylitis.

Published: 2005-05-09 06:57:00

Updated: 2005-05-09 06:57:00

Enbrel injection of Wyeth Korea has been approved of its NHI reimbursement for the indication of ankylosing spondylitis effective from May. Now, the portion of patient's payment for Enbrel has been cut down to 260 thousand won from 1,310 thousand won.

Ankylosing spondylitis is a chronic inflam...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK